Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20505 | 25917981 | Obes Surg | Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. | 2015 | Details |
| A20506 | 25917783 | Gastroenterology | Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. | 2015 | Details |
| A20507 | 25917329 | FASEB J | Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. | 2015 | Details |
| A20508 | 25916635 | Biochim Biophys Acta | Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway. | 2015 | Details |
| A20509 | 25916070 | Hepatogastroenterology | Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis. | 2015 | Details |
| A20510 | 25915743 | Nutr Diabetes | Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity. | 2015 | Details |
| A20511 | 25915484 | Curr Drug Targets | Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20512 | 25914777 | World J Hepatol | Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20513 | 25914775 | World J Hepatol | Influence of cirrhosis in cardiac surgery outcomes. | 2015 | Details |
| A20514 | 25914480 | World J Gastroenterol | Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. | 2015 | Details |
| A20515 | 25914452 | World J Gastroenterol | Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy. | 2015 | Details |
| A20516 | 25914296 | Hepatology | Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. | 2015 | Details |
| A20518 | 25913781 | Endocr J | Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011. | 2015 | Details |
| A20519 | 25913437 | Aliment Pharmacol Ther | Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. | 2015 | Details |
| A20522 | 25910858 | Environ Toxicol Pharmacol | Nonalcoholic fatty liver disease induced by 13-week oral administration of 1,3-dichloro-2-propanol in C57BL/6J mice. | 2015 | Details |
| A20523 | 25910576 | Acta Biochim Biophys Sin (Shanghai) | Exendin-4 regulates redox homeostasis in rats fed with high-fat diet. | 2015 | Details |
| A20524 | 25910377 | Turk J Gastroenterol | Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A20525 | 25910371 | Turk J Gastroenterol | The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. | 2014 | Details |
| A20526 | 25910362 | Turk J Gastroenterol | Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash. | 2014 | Details |
| A20527 | 25910299 | Turk J Gastroenterol | A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis. | 2014 | Details |
| A20528 | 25910292 | Turk J Gastroenterol | Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives. | 2014 | Details |
| A20529 | 25909884 | Cell Death Differ | Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. | 2015 | Details |
| A20530 | 25908607 | Nutr Clin Pract | Finding the Best Waist Circumference Measurement Protocol in Patients With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20531 | 25906757 | J Endocrinol Invest | 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. | 2015 | Details |
| A20532 | 25906661 | Lik Sprava | [Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transaminases level]. | 2015 | Details |
| A20533 | 25906659 | Lik Sprava | [Optimization of long-term treatment with rosuvastatin of patients with myocardial infarction in combination with non-alcoholic steatohepatitis]. | 2015 | Details |
| A20534 | 25906652 | Lik Sprava | [State of intestinal microbiota in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20535 | 25905791 | Food Funct | Differences and similarities in hepatic lipogenesis, gluconeogenesis and oxidative imbalance in mice fed diets rich in fructose or sucrose. | 2015 | Details |
| A20536 | 25905490 | PLoS One | Higher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong. | 2015 | Details |
| A20542 | 25904325 | Mol Biol Cell | CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitis. | 2015 | Details |
| A20543 | 25904096 | J Gastroenterol | Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy. | 2015 | Details |
| A20544 | 25897647 | Crit Rev Food Sci Nutr | The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A20545 | 25896720 | Pharmacology | Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice. | 2015 | Details |
| A20546 | 25896250 | Mol Ther | Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels. | 2015 | Details |
| A20547 | 25894944 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. | 2015 | Details |
| A20548 | 25894568 | Clin Exp Med | Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. | 2015 | Details |
| A20549 | 25893821 | Pediatr Obes | TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. | 2015 | Details |
| A20550 | 25892963 | Int J Biol Sci | ER stress and autophagy dysfunction contribute to fatty liver in diabetic mice. | 2015 | Details |
| A20551 | 25892944 | Malays J Med Sci | What is Obesity Doing to Your Gut? | 2015 | Details |
| A20552 | 25892859 | World J Gastroenterol | Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. | 2015 | Details |
| A20553 | 25892149 | Food Funct | Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress. | 2015 | Details |
| A20554 | 25891086 | Acta Pharmacol Sin | Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. | 2015 | Details |
| A20555 | 25890430 | Obes Res Clin Pract | Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease. | 2014 | Details |
| A20556 | 25890223 | Lipids Health Dis | Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study. | 2015 | Details |
| A20557 | 25889212 | J Transl Med | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? | 2015 | Details |
| A20558 | 25887687 | Clin Res Hepatol Gastroenterol | Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis. | 2015 | Details |
| A20559 | 25887357 | Diabetes Care | Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. | 2015 | Details |
| A20560 | 25886887 | BMC Gastroenterol | Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. | 2015 | Details |
| A20561 | 25885947 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2015 | Details |
| A20562 | 25884354 | BMC Cancer | Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma. | 2015 | Details |
| A20563 | 25882223 | Curr Drug Targets | Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20564 | 25881230 | BMC Gastroenterol | Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model. | 2015 | Details |
| A20565 | 25880979 | Zhonghua Gan Zang Bing Za Zhi | [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis]. | 2015 | Details |
| A20566 | 25880912 | BMC Gastroenterol | Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. | 2015 | Details |
| A20567 | 25880591 | Mol Cancer | Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver. | 2015 | Details |
| A20568 | 25879672 | Liver Int | Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. | 2015 | Details |
| A20569 | 25877813 | Diabetes Care | Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. | 2015 | Details |
| A20570 | 25877295 | Endocr J | Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice. | 2015 | Details |
| A20571 | 25877002 | Scand J Gastroenterol | The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus. | 2015 | Details |
| A20572 | 25876871 | Zhonghua Liu Xing Bing Xue Za Zhi | [Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility: a meta-analysis]. | 2015 | Details |
| A20573 | 25876863 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease]. | 2015 | Details |
| A20574 | 25876706 | J Clin Immunol | Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial. | 2015 | Details |
| A20575 | 25876566 | Intern Med | Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan. | 2015 | Details |
| A20576 | 25875942 | PLoS One | LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD). | 2015 | Details |
| A20577 | 25875390 | Atherosclerosis | Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men. | 2015 | Details |
| A20578 | 25875369 | Indian J Gastroenterol | Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India. | 2015 | Details |
| A20579 | 25875119 | Nutrients | A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. | 2015 | Details |
| A20580 | 25873949 | Int J Endocrinol | Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome. | 2015 | Details |
| A20581 | 25873773 | Mediators Inflamm | OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. | 2015 | Details |
| A20582 | 25873639 | Gut | Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. | 2015 | Details |
| A20583 | 25873207 | Aliment Pharmacol Ther | Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. | 2015 | Details |
| A20584 | 25873078 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. | 2015 | Details |
| A20585 | 25871295 | Mar Drugs | Anti-obesity activity of the marine carotenoid fucoxanthin. | 2015 | Details |
| A20586 | 25870102 | Drug Metab Dispos | Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics. | 2015 | Details |
| A20587 | 25869925 | Obes Surg | Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test. | 2015 | Details |
| A20588 | 25869913 | Nat Rev Gastroenterol Hepatol | Paediatric gastroenterology. On a knife-edge--weight-loss surgery for NAFLD in adolescents. | 2015 | Details |
| A20589 | 25869759 | Wien Klin Wochenschr | Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives. | 2015 | Details |
| A20590 | 25869616 | J Endocrinol | 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes. | 2015 | Details |
| A20591 | 25868633 | Dig Dis Sci | Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice. | 2015 | Details |
| A20592 | 25867030 | J Gastroenterol Hepatol | Clinical outcomes of cryptogenic compared with non-cryptogenic cirrhosis: A retrospective cohort study. | 2015 | Details |
| A20593 | 25866601 | World J Hepatol | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20594 | 25866366 | Sci Rep | Acute exercise does not decrease liver fat in men with overweight or NAFLD. | 2015 | Details |
| A20595 | 25865747 | Obesity (Silver Spring) | Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity. | 2015 | Details |
| A20596 | 25865685 | Hepatobiliary Pancreat Dis Int | Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease. | 2015 | Details |
| A20597 | 25865049 | Gastroenterology | Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20599 | 25864208 | Ann Hepatol | Obesity as a cause of hepatocellular carcinoma. | 2016 | Details |
| A20601 | 25863524 | J Hepatol | Effect of aerobic exercise training dose on liver fat and visceral adiposity. | 2015 | Details |
| A20602 | 25863110 | Clin Biochem | Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals. | 2015 | Details |
| A20604 | 25859289 | Clin Epigenetics | Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. | 2015 | Details |
| A20605 | 25856141 | PLoS One | Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study. | 2015 | Details |
| A20606 | 25855666 | Acta Radiol | A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. | 2015 | Details |
| A20607 | 25854911 | Wien Klin Wochenschr | Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease. | 2015 | Details |
| A20608 | 25853894 | Horm Metab Res | A Nonclassical Monocyte Phenotype in Peripheral Blood is Associated with Nonalcoholic Fatty Liver Disease: A Report from an EMIL Subcohort. | 2015 | Details |
| A20609 | 25852271 | World J Gastroenterol | Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C. | 2015 | Details |
| A20610 | 25852263 | World J Gastroenterol | Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2015 | Details |
| A20612 | 25851235 | Mol Genet Genomics | Transcriptional networks implicated in human nonalcoholic fatty liver disease. | 2015 | Details |
| A20613 | 25850622 | Curr Drug Targets | Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20615 | 25850006 | Cardiovasc Diabetol | Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients. | 2015 | Details |
| A20616 | 25849950 | Nutrients | Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease. | 2015 | Details |
| A20617 | 25849936 | PLoS One | The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice. | 2015 | Details |